Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis

Tesemma Sileshia Department of Pharmacy, Ambo University, Ambo, Ethiopia;b Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, EthiopiaView further author information

Eyasu Makonnenb Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia;c Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, EthiopiaView further author information

Nigus Fikrie Teleled Department of Laboratory Medicines, Karolinska Institutet, Stockholm, SwedenView further author information

Victoria Barclayd Department of Laboratory Medicines, Karolinska Institutet, Stockholm, SwedenView further author information

Alimuddin Zumlae Department of Infection, Division of Infection and Immunity, University College London; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKView further author information

Eleni Aklilluf Department of Global Public Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
View further author information

Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date